Brooks O'Neil
Stock Analyst at Lake Street
(0.53)
# 4,177
Out of 5,142 analysts
34
Total ratings
23.53%
Success rate
-21.71%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $5.17 | +93.42% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $2.82 | +183.69% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $24.57 | -51.16% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.79 | +67.01% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $2.14 | +834.58% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $92.94 | +18.36% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $13.70 | +118.98% | 1 | Feb 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $4.85 | +436.08% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $52.00 | +5.77% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $13.01 | +38.36% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $9.36 | +113.68% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.99 | +25.31% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $24.26 | +7.17% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.49 | +2,134.86% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $24.25 | +425.77% | 1 | Sep 15, 2020 |
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $5.17
Upside: +93.42%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $2.82
Upside: +183.69%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $24.57
Upside: -51.16%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.79
Upside: +67.01%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $2.14
Upside: +834.58%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $92.94
Upside: +18.36%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $13.70
Upside: +118.98%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $4.85
Upside: +436.08%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $52.00
Upside: +5.77%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $13.01
Upside: +38.36%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $9.36
Upside: +113.68%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $3.99
Upside: +25.31%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $24.26
Upside: +7.17%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.49
Upside: +2,134.86%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $24.25
Upside: +425.77%